You are here

MPX Bioceutical Corporation

MPX Logo
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
MPX
CSE Index: 
Currency: 


MPX Bioceutical Corporation (formerly known as The Canadian Bioceutical Corporation) is a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets. The issuer’s foundation is built on its profitable operations in Arizona, with two Health 4 Life Dispensaries and well established Melting Point Extracts (MPX) Brand and GreenMart which holds cultivation and production licenses for both the medical and “adult use” sectors in Nevada and is already selling wholesale into the Nevada medical cannabis market. The business has also optioned suitable locations and intends to enter the higher-margin retail arena by applying for at least two dispensary licenses in the Las Vegas market which will operate under the “Health for Life” brand. MPX is currently building-out facilities in Fall River, Massachusetts, which includes a 40,000 square foot property zoned and licensed for cannabis cultivation and a retail dispensary. MPX also manages and has options to purchase three dispensaries and one production facility in Maryland . MPX plans to replicate its success in Arizona to become a dominant multi-state operator.

You are here

MPX Bioceutical Corporation (MPX)

SEDAR Information

Company Info

Address
Yonge Norton Centre
5255 Yonge Street, Suite 701
Toronto, ON M2N 6P4
Canada
Phone
416-840-3725
Fax
877-595-1828
Email
info@mpxbioceutical.com
Website
http://www.mpxbioceutical.com
Listing date
Friday, January 27, 2017
Transfer Agent
Computershare Investor Services Inc.
Auditor
Deloitte LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
404,014,987
Reserved for Issuance: 
249,197,277

Company Officers

W. Scott Boyes, Chairman, President and Chief Executive Officer
Elizabeth M. Stavola, Chief Operating Officer
David McLaren, Chief Financial Officer

Bulletins

06/02/2019

2019-0215 - Delist - MPX Bioceutical Corporation (MPX)

Le 6 février/February 2019

Following the completion of the Arrangement as set out in the Company's management information circular (the "Circular") dated December 11, 2018 and approved by the Company's security holders at the Company's special meeting held on January 15, 2019 (the "Special Meeting"), the common shares of MPX Bioceutical Corporation will be delisted at the market close today February 6, 2019.

Advertisement

Publicité

Latest CSE News

Upcoming Events

04_30_Planet_Microcap_Showcase_2019_Website

Planet MicroCap Showcase 2019

Tuesday, April 30, 2019 (All day) to Thursday, May 2, 2019 (All day)
04_30_Technology_Developments_IR_Website

CIRI: Technology Developments and the Impact on IR

Tuesday, April 30, 2019 -
11:45am to 1:30pm
05_20_Collision_Website

Collision

Monday, May 20, 2019 (All day) to Thursday, May 23, 2019 (All day)